Premium
RXElite Inc (CE) (RXEI)
USOTC
Hot Features
Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
ORCHARD PARK, N.Y., Nov. 25 /PRNewswire-FirstCall/ -- MINRAD International, Inc. (AMEX:BUF) today announced that it has terminated its Distribution Agreement for anesthetics for the human market...
ORCHARD PARK, N.Y., Sept. 11 /PRNewswire-FirstCall/ -- MINRAD International, Inc. (AMEX:BUF) today announced that it has notified RxElite Holdings, Inc., a wholly-owned subsidiary of RxElite...
NEW YORK, June 11 /PRNewswire/ -- WallSt.net's 3-Minute Press Show is a daily video program hosted by WallSt.net reporter, Tracee Tolentino. Shows air Monday through Friday on:...
MERIDIAN, Idaho, March 21 /PRNewswire-FirstCall/ -- RxElite, Inc. (OTC:RXEI) (BULLETIN BOARD: RXEI) , a developer, manufacturer, and marketer of specialty generic prescription drug products...
MERIDIAN, Idaho, March 18 /PRNewswire-FirstCall/ -- RxElite, Inc. (OTC:RXEI) (BULLETIN BOARD: RXEI) , a developer, manufacturer, and marketer of specialty generic prescription drug products...
RxElite Subsidiary, Fintech Expands Pipeline, Provides Critical API's and Access to Multiple non-US Companies MERIDIAN, Idaho, March 10 /PRNewswire-FirstCall/ -- RxElite, Inc. (OTC:RXEI...
MERIDIAN, Idaho, Jan. 22 /PRNewswire-FirstCall/ -- RxElite, Inc. (OTC:RXEI) (BULLETIN BOARD: RXEI) , a developer, manufacturer, and marketer of specialty generic prescription drug products...
MERIDIAN, Idaho, Jan. 16 /PRNewswire-FirstCall/ -- RxElite Inc., (OTC:RXEI) (BULLETIN BOARD: RXEI) a developer, manufacturer, and marketer of specialty generic prescription drug products...
MERIDIAN, Idaho, Jan. 10 /PRNewswire-FirstCall/ -- RxElite, Inc. (OTC:RXEI) (BULLETIN BOARD: RXEI) , a developer, manufacturer, and marketer of specialty generic prescription drug products...
MERIDIAN, Idaho, Jan. 8 /PRNewswire-FirstCall/ -- RxElite, Inc. (OTC:RXEI) (BULLETIN BOARD: RXEI) , a developer, manufacturer, and marketer of specialty generic prescription drug products...
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 26 | 9.9E-5 | 9900 | 1.0E-6 | 0.0001 | 1.0E-6 | 850 | 8.835E-5 | CS |
| 52 | 9.9E-5 | 9900 | 1.0E-6 | 0.0001 | 1.0E-6 | 550 | 6.85E-5 | CS |
| 156 | 9.9E-5 | 9900 | 1.0E-6 | 0.0001 | 1.0E-6 | 987 | 8.796E-5 | CS |
| 260 | 9.9E-5 | 9900 | 1.0E-6 | 0.0004 | 1.0E-6 | 26626 | 3.127E-5 | CS |
| Aucune Discussion Trouvée |
| Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
